Related Experiment Video
Updated: Sep 11, 2025

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Published on: June 2, 2022
From animal tissue to engineered cells: biotechnological advances in sulfated glycosaminoglycan production
Aditi Dey Tithi1, Yuefan Song2, Hana Zeghal1
1Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, United States; Department of Chemical and Biological Engineering, Troy, NY, United States.
Abstract:
Biotechnological strategies are rapidly advancing the production of sulfated glycosaminoglycans (GAGs), such as chondroitin sulfate and heparin, offering animal-free alternatives with greater safety and structural control. This article examines key developments across microbial, enzymatic, and synthetic platforms, highlighting innovations in metabolic engineering, sulfotransferase optimization, and cofactor regeneration. Case studies in both chondroitin and heparin biosynthesis illustrate how systems biology and protein design are addressing long-standing bottlenecks. We also discuss current limitations and future directions needed to realize scalable, clinically relevant GAG bioproduction.
Related Concept Videos
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Glycosylation
Glycosylation occurs in...

